[go: up one dir, main page]

BR9809113A - Novos intermediários e processo para sua preparação - Google Patents

Novos intermediários e processo para sua preparação

Info

Publication number
BR9809113A
BR9809113A BR9809113-1A BR9809113A BR9809113A BR 9809113 A BR9809113 A BR 9809113A BR 9809113 A BR9809113 A BR 9809113A BR 9809113 A BR9809113 A BR 9809113A
Authority
BR
Brazil
Prior art keywords
preparation
new intermediaries
thienyl
intermediaries
new
Prior art date
Application number
BR9809113-1A
Other languages
English (en)
Other versions
BR9809113B1 (pt
Inventor
Alain Heymes
Bertrand Castro
Maria Bakonyi
Marianna Csatarine Nagy
Leventene Molnar
Original Assignee
Sanofi Synthelabo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Inc filed Critical Sanofi Synthelabo Inc
Publication of BR9809113A publication Critical patent/BR9809113A/pt
Publication of BR9809113B1 publication Critical patent/BR9809113B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"NOVOS INTERMEDIáRIOS E PROCESSO PARA SUA PREPARAçãO" Trata-se de um processo para a preparação de [2 - (2 - tienil) -etil - amino] - (2 -halogeno-fenil) -acetonitrilas da fórmula genérica (I), a partir de 2 - (2 - tienil) -etil-amina, cianeto de metal alcalino e o-halogeno-benzaldeído. Os compostos da fórmula genérica (I) são internediários valiosos.
BRPI9809113-1A 1997-05-13 1998-05-11 [2-(2-tienil) -etilamino] -(2-halogeno-fenil) -acetonitilas como intermediários e processo para sua preparação. BR9809113B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9700886A HU225504B1 (en) 1997-05-13 1997-05-13 Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HUP9700886 1997-05-13
PCT/HU1998/000046 WO1998051682A1 (en) 1997-05-13 1998-05-11 New intermediates and process for the preparation thereof

Publications (2)

Publication Number Publication Date
BR9809113A true BR9809113A (pt) 2000-08-01
BR9809113B1 BR9809113B1 (pt) 2010-03-09

Family

ID=89995121

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809113-1A BR9809113B1 (pt) 1997-05-13 1998-05-11 [2-(2-tienil) -etilamino] -(2-halogeno-fenil) -acetonitilas como intermediários e processo para sua preparação.

Country Status (14)

Country Link
US (1) US6215005B1 (pt)
EP (1) EP0981525B1 (pt)
JP (1) JP4279903B2 (pt)
AT (1) ATE258551T1 (pt)
AU (1) AU7444698A (pt)
BR (1) BR9809113B1 (pt)
CA (1) CA2288637C (pt)
DE (1) DE69821347T2 (pt)
DK (1) DK0981525T3 (pt)
ES (1) ES2213900T3 (pt)
HU (1) HU225504B1 (pt)
NO (1) NO325305B1 (pt)
PT (1) PT981525E (pt)
WO (1) WO1998051682A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
US20040250673A1 (en) * 2003-06-10 2004-12-16 Salerno Paul Michael Ergonomic pedal board
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
ATE455778T1 (de) 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
JP2007513889A (ja) * 2004-09-21 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド 結晶性クロピドグレル臭酸塩及びその調製方法
CA2594763A1 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
WO2007032023A2 (en) 2005-07-12 2007-03-22 Rpg Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
JP2009543759A (ja) * 2006-04-27 2009-12-10 アイエヌディー−スイフト ラボラトリーズ リミテッド クロピドグレル硫酸水素塩の多形相を調製するプロセス
WO2008019053A2 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
KR102860417B1 (ko) * 2023-08-21 2025-09-17 ㈜분자와물질 다성분, 단일반응에 의한 질소-치환된 아미노산을 포함하는 테트라하이드로티에노피리딘 유도체의 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508455A1 (fr) 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et (thienyl-3)-2 ethylamines
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2614619B1 (fr) 1987-04-29 1989-09-15 Sanofi Sa Procede de preparation de n-((chloro-2)-benzyl) (thienyl-2)-2 ethylamine
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
IL128813A0 (en) * 1996-09-12 2000-01-31 Rhone Poulenc Rorer Pharma Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines

Also Published As

Publication number Publication date
DE69821347T2 (de) 2004-12-02
JP4279903B2 (ja) 2009-06-17
CA2288637C (en) 2005-11-15
ATE258551T1 (de) 2004-02-15
HUP9700886A3 (en) 2000-06-28
HU9700886D0 (en) 1997-07-28
BR9809113B1 (pt) 2010-03-09
DK0981525T3 (da) 2004-05-10
WO1998051682A1 (en) 1998-11-19
NO325305B1 (no) 2008-03-25
HUP9700886A2 (hu) 1999-09-28
HU225504B1 (en) 2007-01-29
JP2001525817A (ja) 2001-12-11
US6215005B1 (en) 2001-04-10
NO995531D0 (no) 1999-11-12
ES2213900T3 (es) 2004-09-01
EP0981525B1 (en) 2004-01-28
PT981525E (pt) 2004-05-31
EP0981525A1 (en) 2000-03-01
AU7444698A (en) 1998-12-08
DE69821347D1 (de) 2004-03-04
NO995531L (no) 1999-12-13
CA2288637A1 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
BR9809113A (pt) Novos intermediários e processo para sua preparação
BR9809111A (pt) Novos intermediários e processo para sua preparação
PT960109E (pt) Processo para preparacao de tolterodina
BR9809112A (pt) Novo processo para preparação de uma substância farmacologicamente ativa
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
BR0002073A (pt) Processo para a preparação de um composto quiral
BR9805355A (pt) Processo contínuo para a preparação de polímeros.
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9914883A (pt) Processo para a racemização
BR9809143A (pt) Processo para sintetizar composto
BR9400016A (pt) Processo para preparação de compostos, e compostos
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
BR0009453A (pt) Processo para a preparação de um composto
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR9712773A (pt) Processo para a sìntese de benzotiofenos
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
BR0012481A (pt) Processo para desacilação de lipodepsipeptìdeos
AR017787A1 (es) Un catalizador de complejo de metal de monociclopentadienilo sin puente y un procedimiento para la produccion de poliolefina
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
BR9909756A (pt) Processo para a preparação de um composto
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
BR9803388A (pt) Processo para a preparação de um composto de 4,6-bi (arilóxi)-pirimidina assimétrico.
BR9507857A (pt) Um processo para a preparação de derivados de 5,6-Diidroxi-2-amino-1,2,3,4-tetraidronaftaleno
BR9808047A (pt) Processo para a preparação de 2-nitroguanidinas 1,3-dissubstituìdas
BR9607860A (pt) Processo para a preparação de 4,6-dimetóx12-((fenóxicarbonil)-amino)-pirimidina

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SANOFI-AVENTIS (FR)

Free format text: ALTERADO DE: SANOFI-SYNTHELABO

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/03/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 09.03.2020